• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Biol Macromol . Self-assembling nanoparticle vaccine elicits a robust protective immune response against avian influenza H5N6 virus in chicken

tetano

Editor, Senior Moderator
Int J Biol Macromol


. 2024 Dec 4:138405.
doi: 10.1016/j.ijbiomac.2024.138405. Online ahead of print. Self-assembling nanoparticle vaccine elicits a robust protective immune response against avian influenza H5N6 virus in chickens

Taoran Chen[SUP] 1 [/SUP], Yinze Gao[SUP] 1 [/SUP], Xingtao Chen[SUP] 1 [/SUP], Yajing Dong[SUP] 1 [/SUP], Shiqian Wang[SUP] 1 [/SUP], Qiao Huang[SUP] 1 [/SUP], Shaorong Lin[SUP] 1 [/SUP], Jiaxin Wang[SUP] 1 [/SUP], Ming Liao[SUP] 2 [/SUP], Huiying Fan[SUP] 3 [/SUP]



Affiliations
Abstract

The continuous circulation and evolution of the H5N6 subtype highly pathogenic avian influenza virus (HPAIV) challenge the development of the global poultry industry and human public health security. To address the potential threat of the H5N6 virus, a secure and efficacious vaccine is urgent. In our research, a self-assembling nanoparticle vaccine presenting the hemagglutinin of the H5N6 AIV was developed based on the ferritin antigen display platform. The results showed that a single-dose vaccination of this nanoparticle vaccine elicited potent hemagglutination inhibition (HI) antibody responses and neutralizing antibody responses in the chickens. Meanwhile, the fused HA-ferritin nanoparticle vaccine induced significantly higher levels of Th1/Th2 immune responses. After a lethal attack with the H5N6 virus, the fused HA-ferritin nanoparticle vaccine conferred chickens with 100 % (10/10) challenge protection. Importantly, the fused HA-ferritin nanoparticle with only 2[SUP]8[/SUP] hemagglutination units (HAU) provided chickens with immune protection comparable to commercial inactivated vaccines and protected the chickens from severe lung pathological damage. These results in our study support the superiority of ferritin as an antigen display platform and suggest that self-assembled nanoparticle vaccines based on this platform possess the potential as an avian influenza candidate vaccine.

Keywords: Antigen display platform; Avian influenza virus; Ferritin; H5N6 subtype; Hemagglutinin; Self-assembling nanoparticle.

 
Back
Top Bottom